Astec LifeSciences Limited — Others, 09-12-2024: Copy of Newspaper Publication

Astec LifeSciences Limited's Committee of Independent Directors has provided its rationale on an open offer to acquire up to 50,99,035 equity shares at an enhanced price of INR 1,094.96 each, representing 26% of the expanded voting share capital. This move is spearheaded by a group of prominent acquirers including Nadir Godrej and Tanya Dubash, among others. The committee considers the offer price fair in light of market conditions and encourages public shareholders to evaluate the offer independently. This development may positively influence investor sentiment by indicating robust interest from key shareholders while also presenting a potential liquidity opportunity for existing investors.